|
|
Volumn 57, Issue 3, 2001, Pages 565-566
|
|
Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy [2] (multiple letters)
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
C PEPTIDE;
CARBAMAZEPINE;
CARNITINE;
FATTY ACID;
GENE PRODUCT;
GLUCOSE;
INSULIN;
LAMOTRIGINE;
LEPTIN;
PALMITIC ACID;
VALPROIC ACID;
ANTICONVULSANT THERAPY;
BODY MASS;
BODY WEIGHT;
CALORIMETRY;
CARDIOVASCULAR DISEASE;
CEREBROVASCULAR DISEASE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
CORONARY RISK;
DRUG METABOLISM;
ENERGY EXPENDITURE;
EPILEPSY;
FATTY ACID OXIDATION;
FEMALE;
GLUCOSE BLOOD LEVEL;
HUMAN;
HYPERINSULINEMIA;
INSULIN RELEASE;
LETTER;
OBESITY;
ORAL GLUCOSE TOLERANCE TEST;
PANCREAS ISLET BETA CELL;
PRIORITY JOURNAL;
PROTEIN BINDING;
WEIGHT GAIN;
|
|
EID: 0035859907
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: 10.1212/WNL.57.3.565-a Document Type: Letter |
|
Times cited : (10)
|
|
References (0)
|
